Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.840
-0.340 (-15.60%)
May 18, 2026, 4:00 PM EDT - Market closed
Equillium Market Cap
Equillium has a market cap or net worth of $116.34 million as of May 19, 2026. Its market cap has increased by 675.47% in one year.
Market Cap
116.34M
Enterprise Value
55.71M
1-Year Change
675.47%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $116.34M, a decrease of -50.40%. That is a compound annual growth rate of -8.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 116.34M | 23.26% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agenus | 131.26M |
| Polaryx Therapeutics | 130.67M |
| Fractyl Health | 127.93M |
| Pyxis Oncology | 126.97M |
| Genelux | 126.57M |
| Alpha Cognition | 125.20M |
| OnKure Therapeutics | 124.42M |
| Coya Therapeutics | 115.64M |